483
Meiji Seika Pharmatech Co., Ltd.FDA 483 - Meiji Seika Pharmatech Co., Ltd. - April 08, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Meiji Seika Pharma Co., Ltd. in Odawara, Japan, was inspected and cited for significant deficiencies across its laboratory and quality systems. Observations included widespread data integrity issues, failures in quality control unit procedures, and inadequate investigation of unexplained discrepancies. These issues indicate a lack of robust controls over data accuracy, quality processes, and deviation management.
- Office
- Office of Partnerships
- Person
Open in Dashboard
ID · 0a564b2c-8718-495d-a6e3-b99e8aeb70ca